top of page
News


New Wave Biotech Partners with Nurasa to Accelerate Sustainable Food and Ingredient Innovations to Scale
New Wave Biotech has partnered with Nurasa to accelerate the scale-up of sustainable food and ingredient innovations. By combining New Wave Biotech’s AI-driven bioprocess simulation software with Nurasa’s physical scale-up infrastructure and commercialisation ecosystem, innovators gain early insight into cost, yield and sustainability—reducing risk and speeding the path from R&D to market-ready production across food and biomanufacturing
Jan 14


New Wave Biotech Launches Biotech-Specific LCA to Empower Sustainable Process Design
New Wave Biotech, an innovator in bioprocess optimisation, has launched the industry’s first biotech-specific Life Cycle Assessment (LCA) solution. Fully integrated into its AI-powered process simulation platform, the new capability allows biomanufacturers to quantify and compare the environmental impact of their processes, from climate change and energy output to land and water use, while simultaneously optimising for cost and performance.
Nov 4, 2025


New Wave Biotech and CPI Partner to Tackle Long-Standing Lipid Extraction Challenges
Manchester, 7 October 2025 – New Wave Biotech has announced a partnership with CPI, th e UK’s national translational research and innovat ion organization, to address one of industrial biotechnology’s most persistent hurdles – lipid extraction. The collaboration will combine CPI’s downstream processing expertise with New Wave Biotech’s hybrid AI-powered simulation platform to optimize solvent and non-solvent extraction methods, aiming to enhance scalability, cost efficiency,
Oct 7, 2025


New Wave Biotech and Nurasa explore how food tech can innovate like software
New whitepaper outlines how Lean Startup principles can accelerate food tech innovation Singapore & London – 24 April 2025 – What...
Apr 24, 2025


New Wave Biotech’s AI-Powered Optimisation Drives 55% Cost Reduction for Multus
According to McKinsey, synthetic biology could be worth up to $4 trillion a year over the next ten to 20 years, with use cases ranging...
Mar 4, 2025


New Wave Biotech raises €1.2 million to transform R&D in synbio and alt protein production
AI bioprocess simulation software company New Wave Biotech has raised €1.2 million in its latest funding round through a mix of equity and g
Dec 19, 2024


New Wave Biotech launches Bioprocess Foresight to help biomanufacturing innovators design smarter, commercialise quicker and scale greener
AI bioprocess simulation platform empowers biomanufacturers to make better decisions and processing tech companies to accelerate sales...
Nov 20, 2024


New Wave Biotech selected for the EIT Food Accelerator Network programme
We are delighted to announce that New Wave Biotech has been selected to join the 2024 EIT Food Accelerator Network programme from over...
May 1, 2024


New Wave Biotech awarded funding as part of UKRI’s £13.5m Engineering Biology R&D fund
UK Research and Innovation has launched a pioneering Engineering Biology R&D initiative to boosting synthetic biology's potential to...
Mar 17, 2024
bottom of page
